×
About 23,733 results

ALLMedicine™ Ulcerative Colitis Center

Research & Reviews  7,837 results

Safety and efficacy of tofacitinib for treatment of ulcerative colitis: final analysis ...
https://doi.org/10.1111/apt.16712
Alimentary Pharmacology & Therapeutics; Sandborn WJ, Lawendy N et. al.

Dec 3rd, 2021 - Tofacitinib is an oral, small molecule Janus kinase inhibitor for the treatment of ulcerative colitis. We present final data from OCTAVE Open, an open-label, long-term extension study. The primary objective of OCTAVE Open was to assess the safety ...

P004 Steroid-Free Remission in Patients With Ulcerative Colitis Receiving Tofacitinib i...
https://doi.org/10.14309/01.ajg.0000798616.20791.8c
The American Journal of Gastroenterology; Oleg K, Anna K et. al.

Dec 2nd, 2021 - P004 Steroid-Free Remission in Patients With Ulcerative Colitis Receiving Tofacitinib in Real Clinical Practice.|2021|Oleg K,Anna K,Albina L,Anait B,Dmitriy K,|

P006 The Relationship of Histological Remission With the Duration of the Anamnesis Ulce...
https://doi.org/10.14309/01.ajg.0000798624.19339.03
The American Journal of Gastroenterology; Oleg K, Sergey K et. al.

Dec 2nd, 2021 - P006 The Relationship of Histological Remission With the Duration of the Anamnesis Ulcerative Colitis.|2021|Oleg K,Sergey K,Anna K,Albina L,Karina N,|

P009 Assessing the Status Quo: Ulcerative Colitis Monitoring in a Community GI Practice.
https://doi.org/10.14309/01.ajg.0000798636.78132.29
The American Journal of Gastroenterology; Hartman B, Diana H et. al.

Dec 2nd, 2021 - P009 Assessing the Status Quo: Ulcerative Colitis Monitoring in a Community GI Practice.|2021|Hartman B,Diana H,Casey C,|

P037 Effect of Ozanimod Treatment and Discontinuation on Absolute Lymphocyte Count in M...
https://doi.org/10.14309/01.ajg.0000798748.09138.3f
The American Journal of Gastroenterology; Jean-Frederic C, Geert D et. al.

Dec 2nd, 2021 - P037 Effect of Ozanimod Treatment and Discontinuation on Absolute Lymphocyte Count in Moderate-to-Severe Ulcerative Colitis: Results from a Phase 3 Trial.|2021|Jean-Frederic C,Geert D,Peter I,AnnKatrin P,Denesh C,|

see more →

Guidelines  22 results

COVID-19 Pandemic: Which IBD Patients Need to Be Scoped-Who Gets Scoped Now, Who Can Wa...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665406
Journal of Crohn's & Colitis; Ng SC, Mak JWY et. al.

Oct 22nd, 2020 - Endoscopy is an essential component in the management of inflammatory bowel disease [IBD]. There is a risk of SARS-CoV-2 transmission during endoscopic procedures. The International Organization for the study of IBD [IOIBD] has developed 11 positi...

Pharmacological Management of Adult Outpatients With Moderate to Severely Active Ulcera...
https://doi.org/10.1053/j.gastro.2020.03.011
Gastroenterology

Mar 29th, 2020 - Pharmacological Management of Adult Outpatients With Moderate to Severely Active Ulcerative Colitis: Clinical Decision Support Tool.|2020| ,|

Spotlight: Management of Moderate-to-Severe Ulcerative Colitis.
https://doi.org/10.1053/j.gastro.2020.03.012
Gastroenterology Feuerstein JD, Isaacs KL et. al.

Mar 15th, 2020 - Spotlight: Management of Moderate-to-Severe Ulcerative Colitis.|2020|Feuerstein JD,Isaacs KL,Schneider Y,Siddique SM,Falck-Ytter Y,|

AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Col...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175923
Gastroenterology Feuerstein JD, Isaacs KL et. al.

Jan 17th, 2020 - AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis.|2020|Feuerstein JD,Isaacs KL,Schneider Y,Siddique SM,Falck-Ytter Y,|therapeutic use,standards,diagnosis,immunology,therapy,diagnostic imaging,immunology,p...

Management of ulcerative colitis: summary of updated NICE guidance.
https://doi.org/10.1136/bmj.l5897
BMJ (Clinical Research Ed.); Abdulrazeg O, Li B et. al.

Oct 30th, 2019 - Management of ulcerative colitis: summary of updated NICE guidance.|2019|Abdulrazeg O,Li B,Epstein J, ,|drug therapy,methods,therapeutic use,drug therapy,drug therapy,

see more →

Drugs  361 results see all →

Clinicaltrials.gov  401 results

A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis
https://clinicaltrials.gov/ct2/show/NCT03358706

Nov 25th, 2021 - The purpose of this study is to evaluate the potential effects of an intravenous (IV) induction and subcutaneous (SC) maintenance administration of ustekinumab on the pharmacokinetic (PK) of a cocktail of representative probe substrates of cytochr...

Gene Expression in Chronic Venous Leg Ulcers
https://clinicaltrials.gov/ct2/show/NCT05134597

Nov 25th, 2021 - Chronic Venous Disease (CVD) is a widespread clinical condition widely spread in the western countries, with a prevalence ranging from 10% in adults younger than 30 years of age to nearly 80% for individuals >70 years of age. CVD clinical manifest...

Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
https://clinicaltrials.gov/ct2/show/NCT02536404

Nov 25th, 2021 - The purpose of this study is to determine whether etrasimod (APD334) is a safe and effective treatment for ulcerative colitis after 52 weeks of treatment.

A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis
https://clinicaltrials.gov/ct2/show/NCT01900574

Nov 24th, 2021 - This is an open-label (both [participants and investigator] know what treatment participants will receive) and multicenter study. The study is divided into 2 parts: Part 1: pharmacokinetics portion (Week 0 to Week 14); Part 2: study extension (Wee...

A Study to Evaluate the Long-term Safety and Efficacy of BMS-986165 in Participants With Crohn's Disease or Ulcerative Colitis
https://clinicaltrials.gov/ct2/show/NCT04877990

Nov 24th, 2021 - The purpose of this study is to evaluate the long-term safety and efficacy of BMS-986165 in participants who have previously been enrolled in a BMS-986165 Phase 2 study for moderate to severe Crohn's disease or moderate to severe Ulcerative Colitis.

see more →

News  847 results

Ulcerative colitis: Donor-derived strains predict response in FMT
https://www.mdedge.com/internalmedicine/article/249198/gastroenterology/ulcerative-colitis-donor-derived-strains-predict
Heidi Splete

Nov 30th, 2021 - The Odoribacter splanchnicus strain of human donor-derived bacteria correlated with clinical response to ulcerative colitis in study in which mouse models were colonized with patient-derived strains. Although some recent trials have shown the effe.

Tofacitinib Postmarketing Data Shed Light on JAK Inhibitor Risks
https://www.medscape.com/viewarticle/963183

Nov 17th, 2021 - Additional analyses of a postmarketing trial that was required after the Food and Drug Administration's approval of the Janus kinase inhibitor tofacitinib (Xeljanz, Xeljanz XR) has identified characteristics of older patients with rheumatoid arthr...

Patient Risk, Not Disease Duration, Key to Timing Biologics in IBD
https://www.medscape.com/viewarticle/963195

Nov 17th, 2021 - The decision to Initiate biologics early in the treatment of Crohn's disease (CD) and ulcerative colitis (UC) should be based on complication risk, not on the assumption that earlier treatment produces better results, new research suggests. Result...

Anti-TNF Therapy Tied to Better Outcomes in IBD Patients With COVID-19
https://www.medscape.com/viewarticle/962869

Nov 15th, 2021 - NEW YORK (Reuters Health) - In patients with inflammatory bowel disease (IBD) who contracted COVID-19 infection, anti-tumor necrosis factor (anti-TNF) therapies were associated with more favorable outcomes than corticosteroids or mesalamine in a s...

Assisted Reproductive Therapy Safe in Women With IBD, but Efficacy Mixed
https://www.medscape.com/viewarticle/962480

Nov 9th, 2021 - NEW YORK (Reuters Health) - Assisted reproductive therapy (ART) is safe in women with inflammatory bowel disease (IBD), with outcomes likely similar in women with ulcerative colitis (UC) and medically managed Crohn's disease (CD) compared with the...

see more →

Patient Education  25 results see all →